Previous Close | 130.46 |
Open | 131.68 |
Bid | 133.53 x 1100 |
Ask | 133.25 x 1400 |
Day's Range | 131.51 - 135.58 |
52 Week Range | 74.75 - 139.55 |
Volume | |
Avg. Volume | 3,106,630 |
Market Cap | 51.937B |
Beta (5Y Monthly) | 1.17 |
PE Ratio (TTM) | 104.43 |
EPS (TTM) | 1.29 |
Earnings Date | Apr 25, 2024 - Apr 29, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 149.14 |
Subscribe to Yahoo Finance Plus to view Fair Value for DXCM
In a welcome move, DexCom stock saw its Relative Strength Rating improve from 68 to 73 on Monday. This unique rating measures technical performance by showing how a stock's price movement over the last 52 weeks measures up against that of the other stocks in our database.
DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.
The markets’ professional stock analysts make picking the right equities look easy. But the analysts spend day in and day out with stock data and have built their careers on their stock picks. Retail investors don’t have that advantage when it comes to deciphering the volume of data put up by the markets every day. A tool is necessary to make sense of it and to indicate potentially winning stocks. That’s where the Smart Score comes in. The Smart Score is a data tool designed by TipRanks to gathe